Zelnecirnon (RPT193) is an orally active inhibitor of CCR4 , blocks the recruitment of Th2 inflammatory immune cells into inflamed tissues. Zelnecirnon can be used for allergic inflammation in atopic dermatitis, asthma, and other diseases research In Vitro Zelnecirnon (1 nM-10 μM) inhibits Th2 cells chemotaxis or migration with IC 50 s of ~370 nM. MCE has not independently confirmed the accuracy of these methods. They are for reference only. In Vivo Zelnecirnon (100 mg/kg; p.o.; once daily; 2 d, 1 d before OVA-challenge) reduces skin inflammation in an acute ovalbumin (OVA)-induced atopic dermatitis model in mice. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Acute ovalbumin (OVA)-induced atopic dermatitis model in mouseDosage: 100 mg/kg Administration: Oral gavage; once daily; for 2 days, started 1 day before OVA-challenge (in mouse ear) Result: Decreased the ear thickness significantly. Form:Solid IC50& Target:CCR4
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
Zelnecirnon
CAS number：2366152-15-8 molecular formula：C27H34Cl3N5O2
overview
compound introduction
Specs
| Chinese alias | 泽尔内西尔农 | ||
| English alias | - | ||
| CAS number | 2366152-15-8 | molecular formula | C27H34Cl3N5O2 |
| molecular weight | 566.95 g/mol | Exact mass | ≥99% |
| PSA | - | logp | - |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
No safety information yet
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS
